JP Morgan Chase
BIVI icon

JP Morgan Chase’s BioVie BIVI Stock Holding History

JP Morgan Chase’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7 Hold
5
– – ﹤0.01% 7447
2025
Q4 		$6 Hold
5
– – ﹤0.01% 7348
2025
Q3 		$10 Buy
5
+2
+67% +$8 ﹤0.01% 7315
2025
Q2 		$28 Hold
3
– – ﹤0.01% 6940
2025
Q1 		$29 Hold
3
– – ﹤0.01% 7070
2024
Q4 		$60 Sell
3
-5
-63% -$121 ﹤0.01% 7090
2024
Q3 		$92 Sell
8
-119
-94% -$3.79K ﹤0.01% 7012
2024
Q2 		$5.08K Buy
127
+103
+429% +$4.93K ﹤0.01% 6382
2024
Q1 		$1.29K Buy
24
+2
+9% +$205 ﹤0.01% 6621
2023
Q4 		$2.73K Hold
22
– – ﹤0.01% 6674
2023
Q3 		$7.34K Sell
22
-4
-15% -$1.56K ﹤0.01% 6315
2023
Q2 		$11.4K Buy
+26
New +$17.5K ﹤0.01% 6037

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

JP Morgan Chase's BIVI Position: Q1 2026 in Review

JP Morgan Chase held its BioVie (BIVI) position steady in Q1 2026 at 5 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #7447.

JP Morgan Chase first reported a position in BIVI in Q2 2023 and has held it in 12 quarters since. The position peaked at $11.4K in Q2 2023. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • JP Morgan Chase held 5 shares of BioVie worth $7 as of Q1 2026.
  • JP Morgan Chase left its BioVie share count unchanged in Q1 2026.
  • BioVie made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7447 holding.
  • JP Morgan Chase first reported a position in BioVie in Q2 2023 and has held it in 12 quarters since.
  • JP Morgan Chase's BioVie position peaked at $11.4K in Q2 2023.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.